<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/48-804.51"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/48-804.51/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_48_804_51">
        <akn:num>48-804.51</akn:num>
        <akn:heading>Definitions.</akn:heading>
<akn:subsection eId="subsec_48-804_51_1">
      <akn:num>(1)</akn:num>
      <akn:content><akn:p>“Agent” means an individual who:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_2">
      <akn:num>(2)</akn:num>
      <akn:content><akn:p>“Endorsing prescriber” means a prescriber who has reviewed the therapeutic interchange list and has notified the Boards of Pharmacy and Medicine in writing that he or she has agreed to allow the therapeutic interchange.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_3">
      <akn:num>(3)</akn:num>
      <akn:content><akn:p>“Issue date” means the 1st day of the 4th full calendar month after April 7, 1977, and the day following the end of each year after the 1st such issue date.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_4">
      <akn:num>(4)</akn:num>
      <akn:content><akn:p>“Most commonly used prescription drugs” means the prescription drug products that were most frequently paid for by the Medicaid program operated by the District of Columbia government under a state plan filed in accordance with section 1902 of the Social Security Act (§ 1396a of Title 42, United States Code), in the 3 consecutive months ending 60 days before an issue date.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_5">
      <akn:num>(5)</akn:num>
      <akn:content><akn:p>“Person” means any individual, partnership, corporation, organization, or association.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_6">
      <akn:num>(6)</akn:num>
      <akn:content><akn:p>“Pharmacy” means a pharmacy that provides services to the public on an outpatient basis.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_7">
      <akn:num>(7)</akn:num>
      <akn:content><akn:p>“Prescriber” means a person who is licensed, registered, or otherwise authorized by the District to prescribe and administer prescription drugs for human use in the course of a professional practice.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_8">
      <akn:num>(8)</akn:num>
      <akn:content><akn:p>“Substitute drug product” means a drug product different than the one originally prescribed by a prescriber.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_9">
      <akn:num>(9)</akn:num>
      <akn:content><akn:p>“Therapeutic interchange” means the dispensing of chemically dissimilar but therapeutically equivalent drug products.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_10">
      <akn:num>(10)</akn:num>
      <akn:content><akn:p>“Therapeutic interchange list” means a list of therapeutically equivalent drug products.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-804_51_11">
      <akn:num>(11)</akn:num>
      <akn:content><akn:p>“Therapeutically equivalent drug product” means a drug product that is chemically dissimilar but produces essentially the same therapeutic outcome.</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
